Based on the prognostic potential of PRGs in HCC patients, we established and validated the risk prediction models of five PRGs (GSDME, NLRC4, NLRP6, NOD1 and PLCG1) and separated the HCC patients into a high-risk group and a low-risk group. Here, GSDME is linked to hepatocellular carcinoma.